387 related articles for article (PubMed ID: 36052713)
21. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
22. Deletion of the PPARδ gene exacerbates high-fat diet-induced nonalcoholic fatty liver disease in mice through the gut-liver axis.
Wang YT; Wang FF; Li H; Xu JY; Lu XL; Wang Y
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):121-128. PubMed ID: 37953575
[TBL] [Abstract][Full Text] [Related]
23. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
[TBL] [Abstract][Full Text] [Related]
24. Erchen Decoction alleviates obesity-related hepatic steatosis via modulating gut microbiota-drived butyric acid contents and promoting fatty acid β-oxidation.
Zhang L; Chen N; Zhan L; Bi T; Zhou W; Zhang L; Zhu L
J Ethnopharmacol; 2023 Dec; 317():116811. PubMed ID: 37336336
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets.
Duan Y; Zhong Y; Xiao H; Zheng C; Song B; Wang W; Guo Q; Li Y; Han H; Gao J; Xu K; Li T; Yin Y; Li F; Yin J; Kong X
FASEB J; 2019 Sep; 33(9):10019-10033. PubMed ID: 31167080
[TBL] [Abstract][Full Text] [Related]
26. Zuogui-Jiangtang-Qinggan-Fang alleviates high-fat diet-induced type 2 diabetes mellitus with non-alcoholic fatty liver disease by modulating gut microbiome-metabolites-short chain fatty acid composition.
Zou J; Xiang Q; Tan D; Shi L; Liu X; Wu Y; Yu R
Biomed Pharmacother; 2023 Jan; 157():114002. PubMed ID: 36410120
[TBL] [Abstract][Full Text] [Related]
27. Sinapine reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota.
Li Y; Li J; Su Q; Liu Y
Food Funct; 2019 Jun; 10(6):3637-3649. PubMed ID: 31165837
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.
Lin D; Sun Q; Liu Z; Pan J; Zhu J; Wang S; Jia S; Zheng M; Li X; Gong F
Free Radic Biol Med; 2023 Feb; 195():199-218. PubMed ID: 36586452
[TBL] [Abstract][Full Text] [Related]
29. Supplementation of Inulin with Various Degree of Polymerization Ameliorates Liver Injury and Gut Microbiota Dysbiosis in High Fat-Fed Obese Mice.
Du H; Zhao A; Wang Q; Yang X; Ren D
J Agric Food Chem; 2020 Jan; 68(3):779-787. PubMed ID: 31894986
[TBL] [Abstract][Full Text] [Related]
30. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation.
Zhao Z; Chen L; Zhao Y; Wang C; Duan C; Yang G; Niu C; Li S
Appl Microbiol Biotechnol; 2020 Jun; 104(12):5273-5282. PubMed ID: 32335723
[TBL] [Abstract][Full Text] [Related]
31. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity.
Hwang KA; Hwang YJ; Kim GR; Choe JS
BMC Complement Altern Med; 2015 Oct; 15():347. PubMed ID: 26438035
[TBL] [Abstract][Full Text] [Related]
32. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
[TBL] [Abstract][Full Text] [Related]
33. Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota.
Zhang W; Yu L; Yang Q; Zhang J; Wang W; Hu X; Li J; Zheng G
Phytomedicine; 2024 May; 127():155478. PubMed ID: 38452696
[TBL] [Abstract][Full Text] [Related]
34. Gut dysbiosis contributes to SCFAs reduction-associated adipose tissue macrophage polarization in gestational diabetes mellitus.
Li H; Liu S; Chen H; Zhou L; Chen B; Wang M; Zhang D; Han TL; Zhang H
Life Sci; 2024 Aug; 350():122744. PubMed ID: 38810793
[TBL] [Abstract][Full Text] [Related]
35. Protective Effects of Hydroxyphenyl Propionic Acids on Lipid Metabolism and Gut Microbiota in Mice Fed a High-Fat Diet.
Guo J; Wang P; Cui Y; Hu X; Chen F; Ma C
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839401
[TBL] [Abstract][Full Text] [Related]
36. Triclosan targeting of gut microbiome ameliorates hepatic steatosis in high fat diet-fed mice.
Sun D; Zuo C; Huang W; Wang J; Zhang Z
J Antibiot (Tokyo); 2022 Jun; 75(6):341-353. PubMed ID: 35440769
[TBL] [Abstract][Full Text] [Related]
37. Dietary supplementation with short- and long-chain structured lipids alleviates obesity via regulating hepatic lipid metabolism, inflammation and gut microbiota in high-fat-diet-induced obese mice.
Yue C; Tang Y; Chang M; Wang Y; Peng H; Wang X; Wang Z; Zang X; Ben H; Yu G
J Sci Food Agric; 2024 Jul; 104(9):5089-5103. PubMed ID: 38288873
[TBL] [Abstract][Full Text] [Related]
38. Highland barley β-glucan supplementation attenuated hepatic lipid accumulation in Western diet-induced non-alcoholic fatty liver disease mice by modulating gut microbiota.
Liu H; Nie C; Hu X; Li J
Food Funct; 2024 Feb; 15(3):1250-1264. PubMed ID: 38194248
[TBL] [Abstract][Full Text] [Related]
39.
Li H; Wang XK; Tang M; Lei L; Li JR; Sun H; Jiang J; Dong B; Li HY; Jiang JD; Peng ZG
Gut Microbes; 2024; 16(1):2304159. PubMed ID: 38277137
[TBL] [Abstract][Full Text] [Related]
40. Jamun (Eugenia jambolana Lam.) Fruit Extract Prevents Obesity by Modulating the Gut Microbiome in High-Fat-Diet-Fed Mice.
Xu J; Liu T; Li Y; Liu W; Ding Z; Ma H; Seeram NP; Mu Y; Huang X; Li L
Mol Nutr Food Res; 2019 May; 63(9):e1801307. PubMed ID: 30762938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
